Overview
Welcome
Dear Colleague
You are invited to join us at the 19th International Conference on Malignancies in HIV/AIDS (ICMH). The meeting will be a held at the Natcher Conference Center on the NIH campus on October 24-25, 2024.
This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services.
Recent advances in areas such as viral oncology, immunology, genetics, epidemiology, pathogenesis, early diagnosis, and clinical research will be presented. Our objective is to facilitate the exchange of information between laboratory and clinical researchers so as to accelerate the translation of basic scientific discoveries into clinical applications.
The 19th ICMH will include a Junior Investigator Research In Progress Session. This session will be composed of 7 minute oral presentations (followed by 3 minutes for questions) from selected abstracts from junior investigators describing their research project that is planned or in progress. Junior investigators for this session are defined as investigators who are currently in a fellowship or completed any type of training or fellowship within the last 5 years. The idea behind this session is to allow junior investigators to receive feedback of their presentation prior to the meeting from senior investigators and to present their work to a larger audience. If the abstract is selected for a presentation during this session, the junior investigator will be asked to provide their presentation one week prior to the meeting to an assigned Program Committee member with the appropriate expertise to provide feedback of the presentation. Abstracts not selected for oral presentations will be presented as posters. The Abstract page will require the abstract submitter to select a box to denote that the abstract should be considered for the Junior Investigator In Progress Session.
Registration is free and is required in order to attend. Online registration will close October 17, 2024. If you have any questions contact Geraldina Dominguez domingug@nih.gov.
Abstracts are due by August 16, 2024, 5 PM local time (1700 hr). Late abstracts will not be accepted.
General
Scope of the 19th ICMH
The ICMH is the only forum that is solely focused on presentation of basic, epidemiologic, and clinical aspects of research on malignancies in HIV-infected individuals. Our objective is to enable information exchange between laboratory and clinically based investigators to decrease the interval between basic discovery and clinical application.
This conference will address basic, translational, and clinical research on viral oncology, immunology, co-occurring viral infections, genetics, epidemiology, pathogenesis, drug discovery, early diagnosis, and clinical outcomes in the context of HIV/AIDS.
Who should attend the 19th ICMH?
The format will include invited plenaries as well as oral and poster presentations of submitted abstracts. This conference is organized to provide informational and networking resources for all clinical and laboratory investigators; postdocs; students; physicians; health care workers and others involved, interested, or participating in malignancy research in HIV/AIDS and in tumor virology. Participants from resource-limited countries with endemic virus-associated malignancies are encouraged to submit abstracts.
Reasonable Accommodations
If you are a person with a disability and require any assistive device, service, or other reasonable accommodations to participate in the event, please contact Michelle L. Murray Michelle.Murray@luminacorps.com.
Contact
Scientific content:
Geraldina Dominguez, Ph.D.
Program Co-Chair
19th ICMH Program Committee
Office of HIV and AIDS Malignancy
National Cancer Institute
Meeting logistics:
Michelle L. Murray, CMP, CVEP
Lumina Corps
Michelle.Murray@luminacorps.com